Mast Cell Activation Test in Allergic Disease
Assessment of Mast Cell Activation Diagnostic Test in Patients With Allergic Disease
Sponsor: Chinese University of Hong Kong
Listed as NCT03406325, this observational or N/A phase trial focuses on Anaphylaxis and Asthma and remains completed. Sponsored by Chinese University of Hong Kong, it has been updated 14 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Dec 2021 — Dec 2022 [monthly]
Completed
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
May 2020 — Nov 2020 [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2019 — May 2020 [monthly]
Recruiting
-
Aug 2018 — Mar 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
- Hong Kong Sanatorium & Hospital
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .